Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  ArQule, Inc.    ARQL   US04269E1073

ARQULE, INC.

 (ARQL)
1
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Sector
Healthcare
Biotechnology / Pharmaceuticals
 Biotechnology / Pharmaceuticals
  Pharmaceuticals - Generic / Specialty
Logo
Logo ArQule, Inc.
Surperformance© rating of ArQule, Inc.
Overall rating In sector In country
Trading Rating
Investor Rating
Growth (Revenue)
Valuation - - -
Finances - - -
Profitability
Earnings quality
Business Predictability
PER - - -
Potential
Yield - - -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector Pharmaceuticals - Generic / Specialty
CountryTrading RatingInvestor Rating
ABBVIE INCUSA
ASTRAZENECA PLCUnited Kingdom
TAKEDA PHARMACEUTICAL COMPANY LIMITEDJapan
ALLERGAN, INC.USA
MCKESSON CORPORATIONUSA
VALEANT PHARMACEUTICALS INTL INCCanada
ASTELLAS PHARMA INCJapan
OTSUKA HOLDINGS CO LTDJapan
SUN PHARMACEUTICAL INDUSTRIES LIMITEDINDIA
ZOETIS INCUSA
AMERISOURCEBERGEN CORP.USA
EISAI CO., LTDJapan
GRIFOLS SASpain
PERRIGO COMPANYUSA
FOREST LABORATORIES, INC.USA
MERCK KGAAGermany
YUNNAN BAIYAO GROUP CO., LTDCHINA
ASPEN PHARMACARE HOLDINGS LIMITEDSouth Africa
ONO PHARMACEUTICAL CO., LTD.Japan
SHIONOGI & CO LTDJapan
MITSUBISHI TANABE PHARMA CORPORATIONJapan
ELAN CORPORATION, PLCIreland (Eire)
SINOPHARM HOLDING CO LTDHong Kong
PT KALBE FARMA TBKINDONESIA
KYOWA HAKKO KIRIN CO LTDJapan
Sector Pharmaceuticals - Generic / Specialty
Data source :
© 2013 Thomson Reuters		 Ratings :
© 2013 Surperformance
Advertisement
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Stay Connected :
Copyright © 2013 Surperformance. All rights reserved.